CORRECTED: Pharmas Can't Nix Lidoderm MDL Over $170M Pay-For-Delay Deals
A California federal judge on Tuesday preserved the bulk of consolidated antitrust multidistrict litigation accusing Endo Pharmaceuticals Inc., Teikoku Seiyaku Co. Ltd., and Watson Pharmaceuticals Inc. of illegally deferring competition from...To view the full article, register now.
Already a subscriber? Click here to view full article